The owner of several laboratory companies agreed to pay $26.3 million to resolve allegations that they violated the False Claims Act by ordering medically unnecessary respiratory pathogen panel tests, the Justice Department announced Thursday.
Patrick Britton-Harr owned and operated Provista Health and other corporate entities that sought to profit from the unfolding Covid-19 pandemic by offering Covid tests to nursing homes as a way to bill Medicare for a wide array of medically unnecessary RPP tests, the DOJ said.
The department said Britton-Harr and Provista Health also submitted claims for RPP tests that were never ordered by physicians and …
